Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learned from GRIFFIN and CASSIOPEIA trials?
Multiple Myeloma Hub
Treatment Efficacy Comparison in Newly Diagnosed Multiple Myeloma Patients
Exploring the impact of incorporating DEROTUMAMAB in the treatment regimen for multiple myeloma patients, comparing outcomes with and without maintenance therapy, based on the Griffin and Cassiopeia trials.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
